Type 2 diabetes and macrovascular disease: epidemiology and etiology (Q33762013)

29 July 2017

1 reference

title

Type 2 diabetes and macrovascular disease: epidemiology and etiology (English)

1 reference

29 July 2017

0 references

Clark CM Jr

1

1 reference

29 July 2017

Perry RC

series ordinal

2

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 November 1999

1 reference

29 July 2017

published in

American Heart Journal

1 reference

29 July 2017

volume

138

1 reference

29 July 2017

issue

5 Pt 1

1 reference

29 July 2017

page(s)

S330-3

1 reference

Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994.

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970031-1

Overweight and obesity in the United States: prevalence and trends, 1960-1994

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970031-1

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970031-1

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970031-1

Forum One: Current recommendations about intensification of metabolic control in non-insulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970031-1

Hyperglycemia and microvascular and macrovascular disease in diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970031-1

Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970031-1

Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970031-1

High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men. 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970031-1

Do non-insulin-dependent diabetes mellitus and cardiovascular disease share common antecedents?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970031-1

Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970031-1

Diabetes and cardiovascular disease. The Framingham study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970031-1

Diabetes and Glucose Tolerance as Risk Factors for Cardiovascular Disease: The Framingham Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970031-1

NIDDM and its metabolic control predict coronary heart disease in elderly subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970031-1

Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970031-1

Potentiation of vasculopathy by insulin: implications from an NHLBI clinical alert

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970031-1

The role of hyperglycaemia and hyperinsulinaemia in causing vascular dysfunction in diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970031-1

Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970031-1

Haemodynamic and other effects of sulphonylurea drugs on the heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970031-1

Ten-year survival after acute myocardial infarction: comparison of patients with and without diabetes. SPRINT Study Group. Secondary Prevention Reinfarction Israeli Nifedipine Trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970031-1

Influence of oral antidiabetic treatment on electrocardiac alterations induced by myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970031-1

What kind of cardiovascular alterations could be influenced positively by oral antidiabetic agents?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970031-1

Influence of hypoglycaemic sulphonylureas on the electrophysiological parameters of the heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970031-1

Prevention and treatment of the complications of diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970031-1

Hypertension and diabetes: current issues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970031-1

10.1016/S0002-8703(99)70031-1

7 January 2021

Identifiers

DOI

1 reference

29 July 2017

1 reference